Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard I Walker

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Vaccine|November 13, 2021
Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infantsAnn-Mari Svennerholm, Firdausi Qadri, Anna Lundgren, et al.
Vaccine|August 1, 2009
Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritisJ S Hill Gaston, Robert D Inman, Edward T Ryan, et al.
Vaccine|November 11, 2023
Vaccine value profile for enterotoxigenic Escherichia coli (ETEC)Ibrahim Khalil, John D Anderson, Karoun H Bagamian, et al.
Clinical and Vaccine Immunology : CVI|August 20, 2011
Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccinesClayton Harro, Subhra Chakraborty, Andrea Feller, et al.
Vaccine|July 12, 2005
Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccineDonald H Burr, David Rollins, Lanfong H Lee, et al.
Infection and Immunity|September 25, 2013
Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccineFrancisco J Martinez-Becerra, Xiaotong Chen, Nicholas E Dickenson, et al.
Human Vaccines & Immunotherapeutics|February 23, 2019
A phase I trial of WRSS1, a <i>Shigella sonnei</i> live oral vaccine in Bangladeshi adults and childrenRubhana Raqib, Protim Sarker, K Zaman, et al.
BMC Genomics|June 10, 2016
Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatmentMihai Pop, Joseph N Paulson, Subhra Chakraborty, et al.
Infection and Immunity|January 21, 2010
Assessment of the duration of protection in Campylobacter jejuni experimental infection in humansDavid R Tribble, Shahida Baqar, Daniel A Scott, et al.
Vaccine|March 26, 2004
Meeting summary: possibilities for active and passive vaccination against opportunistic infectionsRichard I Walker, Thomas Blanchard, Jan Matthias Braun, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Vaccine|November 13, 2021
Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infantsAnn-Mari Svennerholm, Firdausi Qadri, Anna Lundgren, et al.
Vaccine|August 1, 2009
Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritisJ S Hill Gaston, Robert D Inman, Edward T Ryan, et al.
Vaccine|November 11, 2023
Vaccine value profile for enterotoxigenic Escherichia coli (ETEC)Ibrahim Khalil, John D Anderson, Karoun H Bagamian, et al.
Clinical and Vaccine Immunology : CVI|August 20, 2011
Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccinesClayton Harro, Subhra Chakraborty, Andrea Feller, et al.
Vaccine|July 12, 2005
Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccineDonald H Burr, David Rollins, Lanfong H Lee, et al.
Infection and Immunity|September 25, 2013
Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccineFrancisco J Martinez-Becerra, Xiaotong Chen, Nicholas E Dickenson, et al.
Human Vaccines & Immunotherapeutics|February 23, 2019
A phase I trial of WRSS1, a <i>Shigella sonnei</i> live oral vaccine in Bangladeshi adults and childrenRubhana Raqib, Protim Sarker, K Zaman, et al.
BMC Genomics|June 10, 2016
Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatmentMihai Pop, Joseph N Paulson, Subhra Chakraborty, et al.
Infection and Immunity|January 21, 2010
Assessment of the duration of protection in Campylobacter jejuni experimental infection in humansDavid R Tribble, Shahida Baqar, Daniel A Scott, et al.
Vaccine|March 26, 2004
Meeting summary: possibilities for active and passive vaccination against opportunistic infectionsRichard I Walker, Thomas Blanchard, Jan Matthias Braun, et al.
Pageof 4